568533-U

Discovery^® HS C18 (5 µm) HPLC Columns

L × I.D. 25 cm × 10 mm, HPLC Column

• Synonim(y): Discovery RP18 HPLC Column
• Kod UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Właściwości

• product name: Discovery^® HS C18 HPLC Column, 5 μm particle size, L × I.D. 25 cm × 10 mm
• Materiały: stainless steel column
• Poziom jakości: 100
• agency: suitable for USP L1
• linia produktu: Discovery^®
• Właściwości: endcapped
• producent / nazwa handlowa: Discovery^®
• opakowanie: 1 ea of
• zakres etykietowania: 20% Carbon loading
• Parametry: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• metody: HPLC: suitable
• dł. × śr. wewn.: 25 cm × 10 mm
• powierzchnia: 300 m²/g
• pokrycie powierzchni: 3.2 μmol/m²
• zanieczyszczenia: <10 ppm metals
• macierz: silica gel, high purity, spherical particle platform; fully porous particle
• grupa aktywna macierzy: C18 (octadecyl) phase
• wielkość cząstki: 5 μm
• wielkość porów: 120 Å
• operating pH range: 2-8
• Zastosowanie: food and beverages
• metoda separacji: reversed phase

Opis

Opis ogólny

Discovery^® HS C18 HPLC column is specifically developed for pharmaceutical analyses and purification.

Zastosowanie

• Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping: This research utilizes the Discovery^® HS C18 HPLC column for its superior selectivity and sensitivity in pharmacogenetic studies, providing vital data for personalized medicine approaches in drug metabolism (Abouir et al., 2024).


• A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies: This study highlights the effectiveness of the Discovery^® HS C18 column in the rapid and accurate analysis of molnupiravir, emphasizing its role in supporting fast-paced pharmaceutical research and development (Reçber et al., 2022).


• Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: This application underlines the Discovery^® HS C18 column′s high sensitivity and robustness in clinical diagnostics, crucial for monitoring therapeutic drugs and their metabolites in complex biological matrices (Maliszewska et al., 2020).

Cechy i korzyści

• Stable, low bleed for LC-MS applications
• Scalable from analytical to preparatory
• Highly stable to ensure excellent run-to-run and lot-to-lot reproducibility
• Higher hydrophobicity for better resolution of difficult analytes

   

Polecane produkty

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informacje prawne

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Ta strona może zawierać tekst przetłumaczony maszynowo.